These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22452358)

  • 1. A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project.
    Ravera S; Monteiro SP; de Gier JJ; van der Linden T; Gómez-Talegón T; Alvarez FJ;
    Br J Clin Pharmacol; 2012 Dec; 74(6):920-31. PubMed ID: 22452358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of a European categorization system for driving-impairing medicines in Iran.
    Harzand Jadidi S; Farahbakhsh M; Sadeghi-Bazargani H; Pourasghar F
    Traffic Inj Prev; 2023; 24(5):387-392. PubMed ID: 37104663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019.
    Gutiérrez-Abejón E; Criado-Espegel P; Pedrosa-Naudín MA; Fernández-Lázaro D; Herrera-Gómez F; Álvarez FJ
    Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease, antiparkinson medicines, and driving.
    Álvarez FJ
    Expert Rev Neurother; 2016 Sep; 16(9):1023-32. PubMed ID: 27464001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The "Driving under the Influence of Drugs, Alcohol and Medicines" (DRUID) project of the European Commission].
    Albrecht M
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S45-6. PubMed ID: 18548371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey.
    Monteiro SP; van Dijk L; Verstraete AG; Alvarez FJ; Heissing M; de Gier JJ
    BMC Public Health; 2012 Jan; 12():59. PubMed ID: 22264358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of guideline implementation for dispensing driving-impairing medicines by National Pharmacy Organizations.
    de Gier H; Bogaard L; Siu VF; Todorov B; Pinto GS; Viegas R; Aldarij N; van Dijk L; Borgsteede SD
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100415. PubMed ID: 38327264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving in Europe: the need of a common policy for drivers with obstructive sleep apnoea syndrome.
    Rodenstein D;
    J Sleep Res; 2008 Sep; 17(3):281-4. PubMed ID: 18651866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Categorization and labeling systems concerning driving-impairing medicines: A scoping review.
    Harzand-Jadidi S; Pourasghar F; Sadeghi-Bazargani H; Farahbakhsh M
    Traffic Inj Prev; 2023; 24(4):287-292. PubMed ID: 36971426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug use and driving].
    Lemaire-Hurtel AS; Goullé JP; Alvarez JC; Mura P; Verstraete AG
    Presse Med; 2015 Oct; 44(10):1055-63. PubMed ID: 25956300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Safety of Medicines in the European Union: From Signals to Action.
    Potts J; Genov G; Segec A; Raine J; Straus S; Arlett P
    Clin Pharmacol Ther; 2020 Mar; 107(3):521-529. PubMed ID: 31621897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulations for controlling fitness to drive].
    Wallin A; Ojala M; Wuoma E
    Duodecim; 1999; 115(6):701-7. PubMed ID: 11859504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Illicit drugs, medications and traffic accidents].
    Goullé JP; Verstraete A; Boulu R; Costentin J; Foucher JP; Raes E; Tillement JP
    Ann Pharm Fr; 2008 Aug; 66(4):196-205. PubMed ID: 18847565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random and systematic errors in case-control studies calculating the injury risk of driving under the influence of psychoactive substances.
    Houwing S; Hagenzieker M; Mathijssen RP; Legrand SA; Verstraete AG; Hels T; Bernhoft IM; Simonsen KW; Lillsunde P; Favretto D; Ferrara SD; Caplinskiene M; Movig KL; Brookhuis KA
    Accid Anal Prev; 2013 Mar; 52():144-53. PubMed ID: 23333321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Antidepressants Use in Spain between 2015 and 2018: Analyses from a Population-Based Registry Study with Reference to Driving.
    Gutiérrez-Abejón E; Herrera-Gómez F; Criado-Espegel P; Álvarez FJ
    Pharmaceuticals (Basel); 2020 Apr; 13(4):. PubMed ID: 32260117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The medical certification for diabetic drivers in selected countries outside Europe].
    Szosland D; Marcinkiewicz A
    Med Pr; 2009; 60(6):543-8. PubMed ID: 20187503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fitness to drive in dementia - theoretical framing and design of a recommendation for German general practice].
    Pentzek M; Michel JV; Ufert M; Vollmar HC; Wilm S; Leve V
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(2):115-23. PubMed ID: 26028448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actual sociomedical aspects of diabetes and fitness to drive private and commercial vehicles and of diabetes and disability].
    Finck H
    MMW Fortschr Med; 2016 Apr; 158 Spec No 1():59-64. PubMed ID: 27090679
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychoactive drugs and accident risk in road traffic].
    Lillsunde P; Langel K; Blencowe T; Kivioja A; Karjalainen K; Lehtonen L
    Duodecim; 2012; 128(18):1877-86. PubMed ID: 23088001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.